Dr. Thomas J. Hudson Net Worth (2022) | wallmine
Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use in U.S., Europe | FiercePharma
AbbVie's risankizumab improves symptoms of psoriatic arthritis in trials
AbbVie shares new Rinvoq data involving patients with psoriatic arthritis - Drug Discovery and Development
Alpine Immune and AbbVie sign $865m immunology deal
AbbVie on Twitter: "Tom Hudson, AbbVie Chief Scientific Officer How it started: How it's going: https://t.co/4o1roia3Yt" / Twitter
Thomas Hudson, M.D - Our R&D Leaders - Our Science | AbbVie
Thomas Hudson's email & phone | AbbVie's Senior Vice Research and Development and Chief Scientific Officer email
AbbVie: ChemBeads, Improving Artificial Intelligence Through Human Ingenuity
AbbVie's Skyrizi nabs psoriatic arthritis nod, its 2nd, shortly after Rinvoq | FiercePharma
AbbVie on Twitter: "Renowned researcher, Tom Hudson, discusses how his work on the Human Genome Project influences his cancer research: https://t.co/NE2p8hD4EE https://t.co/XxW1OwIa8C" / Twitter
70+ "Hudson, Ms" profiles | LinkedIn
Thomas Hudson - DIA 2020 Virtual Global Annual Meeting
AbbVie on Twitter: "#DYK we partner with others to give science an edge against tough diseases like #COVID19 and #cancer? This lets us “remain creative, nimble and innovative as we develop therapies
Strategic Advisory Board
AbbVie's drug shows improvement in psoriatic arthritis symptoms in trials
AbbVie Helps to Advance Gene Therapy for Chronic Retinal Diseases
AbbVie and Google-backed Calico re-commit to anti-ageing mission
Partner Spotlight: Thomas Hudson - Cancer Research Institute (CRI)
AbbVie Makes Large Investment in Regenxbio's Gene Therapy for Retinal Diseases - Eyewire+
Major cash injection for Alphabet and AbbVie's R&D program
AbbVie on Twitter: "Tom Hudson, AbbVie Chief Scientific Officer How it started: How it's going: https://t.co/4o1roia3Yt" / Twitter
